ClinicalTrials.govpublic full text
Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis
end-stage renal disease, prevention of thromboembolic events, hemodialysis, hemodiafiltration, end-stage renal disease (esrd), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854613
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.